A selective COX-2 Inhibitor Melix Capsule launched

 

 

 

COX-2 selective NSAIDs Melix capsules (meloxicam 7.5 mg) are now available.
Melix capsules contain meloxicam, a member of the oxicam series, and have a stronger inhibitory effect on COX-2, which is closely related to pain and inflammatory responses, than COX-1, which is related to the gastrointestinal tract, kidneys, and other side effects. It suppresses inflammation and pain without general side effects. Therefore, it has very low gastrointestinal side effects compared to other NSAIDs that were previously prescribed/taken for long-term arthritis, and is a safe product with significantly lower cerebrovascular and cardiovascular side effects than the specific COX-2 inhibitors rofecoxib (Vioxx/MSD) and celecoxib (Celebrex/Pfizer).

◈ Ingredient content: Meloxicam 7.5mg

◈ Effectiveness
▷ Treatment of short-term symptoms in acute exacerbation of osteoarthritis accompanied by painful ataxia
▷ Long-term treatment of rheumatoid arthritis symptoms
▷ Symptomatic treatment of ankylosing spondylitis

◈ Dosage and usage
▷ Osteoarthritis: 1 capsule (7.5mg) once a day, can be increased to 2 capsules (15mg) a day as needed
▷ Rheumatoid arthritis and ankylosing spondylitis: 2 capsules (15 mg) once a day
(※ This agent should not be administered in excess of 15 mg per day.)

◈ Appearance: Top/bottom blue-green hard capsule containing yellow or light yellow powder

◈ Insurance price: 403 won/C

◈ Claim code: A17604071

◈ Packaging unit: 30, 100 capsules

※ Please refer to the attached document for precautions for use and other detailed information.